FindTrial
Sign In

iodine I 131 monoclonal antibody CC49-deltaCH2

DRUG2 trials

Sponsors

National Cancer Institute (NCI), University of California, San Francisco

Conditions

Adenocarcinoma of the ColonAdenocarcinoma of the RectumColorectal CancerEsophageal CancerGastric CancerPancreatic CancerRecurrent Colon CancerRecurrent Rectal Cancer

Phase 1

Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Recurrent or Persistent Metastatic Colorectal Cancer
CompletedNCT00023933
National Cancer Institute (NCI)Adenocarcinoma of the Colon, Adenocarcinoma of the Rectum, Recurrent Colon Cancer +3
Start: 2001-10-31Updated: 2013-01-25
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Gastrointestinal Cancer
WithdrawnNCT00025532
University of California, San FranciscoColorectal Cancer, Esophageal Cancer, Gastric Cancer +1
Start: 2001-04-30Updated: 2012-09-14